ArticleDermatology and therapy2025

Real-World Skin Clearance and Quality of Life with risankizumab in Patients with Psoriasis with Moderate Skin Involvement and Those Eligible for Systemic Therapy Per International Psoriasis Council Classification.

Bruce Strober et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.